Stock analysis, AI verdict, fundamentals & technical signals
Rating: NEUTRAL
Price: $0.40 Analyst target: $4.00 Upside: 888.14%
Lucid Diagnostics Inc. is a commercial stage medical diagnostic technology company. The company is headquartered in New York, New York.
See the full interactive analysis & chart →Informational only — not investment advice.